Variant report
Variant | nsv964350 |
---|---|
Chromosome Location | chr2:141670995-141677004 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187865458 | chr2:141673861-141673862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150886868 | chr2:141673869-141673870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76269742 | chr2:141673873-141673874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572320660 | chr2:141673903-141673904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532704210 | chr2:141673998-141673999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552141047 | chr2:141674074-141674075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565780705 | chr2:141674076-141674077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534760373 | chr2:141674084-141674085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555054046 | chr2:141674088-141674089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568126387 | chr2:141674089-141674090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191252883 | chr2:141674101-141674102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1429343 | chr2:141674190-141674191 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs11885718 | chr2:141674200-141674201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577195171 | chr2:141674212-141674213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546166027 | chr2:141674216-141674217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552958529 | chr2:141674219-141674220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs139366695 | chr2:141674229-141674230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541527928 | chr2:141674285-141674286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561844927 | chr2:141674303-141674304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184965429 | chr2:141674307-141674308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543983796 | chr2:141674350-141674351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143240045 | chr2:141674384-141674385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138644407 | chr2:141674404-141674405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs398104771 | chr2:141674405-141674406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35253461 | chr2:141674407-141674408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201600359 | chr2:141674408-141674409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562957356 | chr2:141674420-141674421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146695380 | chr2:141674514-141674515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140210902 | chr2:141674525-141674526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564960036 | chr2:141674580-141674581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370110313 | chr2:141674586-141674587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141673800-141674200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:141673800-141674600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:141677000-141677800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |